Schuchter LM - Search Results

1

Autologous hapten-modified melanoma vaccine as postsurgical adjuvant treatment after resection of nodal metastases.

Berd D, Maguire HC Jr, Schuchter LM, Hamilton R, Hauck WW, Sato T, Mastrangelo MJ. Berd D, et al. Among authors: schuchter lm. J Clin Oncol. 1997 Jun;15(6):2359-70. doi: 10.1200/JCO.1997.15.6.2359. J Clin Oncol. 1997. PMID: 9196151 Clinical Trial.

2

Sequential chemotherapy and immunotherapy for the treatment of metastatic melanoma.

Schuchter LM, Wohlganger J, Fishman EK, MacDermott ML, McGuire WP. Schuchter LM, et al. J Immunother (1991). 1992 Nov;12(4):272-6. doi: 10.1097/00002371-199211000-00008. J Immunother (1991). 1992. PMID: 1477078 Clinical Trial.

3

Melanoma of unknown primary site: presentation, treatment, and prognosis--a single institution study. University of Pennsylvania Pigmented Lesion Study Group.

Anbari KK, Schuchter LM, Bucky LP, Mick R, Synnestvedt M, Guerry D 4th, Hamilton R, Halpern AC. Anbari KK, et al. Among authors: schuchter lm. Cancer. 1997 May 1;79(9):1816-21. doi: 10.1002/(sici)1097-0142(19970501)79:9<1816::aid-cncr26>3.0.co;2-#. Cancer. 1997. PMID: 9129001

4

The role of the pathologist in the diagnosis of melanoma.

Elenitsas R, Schuchter LM. Elenitsas R, et al. Among authors: schuchter lm. Curr Opin Oncol. 1998 Mar;10(2):162-9. doi: 10.1097/00001622-199803000-00014. Curr Opin Oncol. 1998. PMID: 9555541 Review.

5

Systemic treatment of metastatic melanoma with chemotherapy.

Green RJ, Schuchter LM. Green RJ, et al. Among authors: schuchter lm. Hematol Oncol Clin North Am. 1998 Aug;12(4):863-75, viii. doi: 10.1016/s0889-8588(05)70028-9. Hematol Oncol Clin North Am. 1998. PMID: 9759584 Free article. Review.

6

Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: impact on the delivery of local-regional radiation therapy.

Moore HC, Mick R, Solin LJ, Sickles C, Mangan PA, Luger SM, Fox KR, Schuchter LM, Loh E, Porter DL, Schuster S, Buzby GP, Glatstein E, Silberstein LE, Stadtmauer EA. Moore HC, et al. Among authors: schuchter lm. Ann Oncol. 1999 Aug;10(8):929-36. doi: 10.1023/a:1008393204854. Ann Oncol. 1999. PMID: 10509154 Free article. Clinical Trial.

7

Phase III multicenter randomized trial of the Dartmouth regimen versus dacarbazine in patients with metastatic melanoma.

Chapman PB, Einhorn LH, Meyers ML, Saxman S, Destro AN, Panageas KS, Begg CB, Agarwala SS, Schuchter LM, Ernstoff MS, Houghton AN, Kirkwood JM. Chapman PB, et al. Among authors: schuchter lm. J Clin Oncol. 1999 Sep;17(9):2745-51. doi: 10.1200/JCO.1999.17.9.2745. J Clin Oncol. 1999. PMID: 10561349 Clinical Trial.

8

Incidence of sentinel node metastasis in patients with thin primary melanoma (< or = 1 mm) with vertical growth phase.

Bedrosian I, Faries MB, Guerry D 4th, Elenitsas R, Schuchter L, Mick R, Spitz FR, Bucky LP, Alavi A, Elder DE, Fraker DL, Czerniecki BJ. Bedrosian I, et al. Ann Surg Oncol. 2000 May;7(4):262-7. doi: 10.1007/s10434-000-0262-z. Ann Surg Oncol. 2000. PMID: 10819365

9

Metastatic melanoma.

Sun W, Schuchter LM. Sun W, et al. Among authors: schuchter lm. Curr Treat Options Oncol. 2001 Jun;2(3):193-202. doi: 10.1007/s11864-001-0033-5. Curr Treat Options Oncol. 2001. PMID: 12057119 Review.

10

Adjuvant interferon therapy for melanoma: high-dose, low-dose, no dose, which dose?

Schuchter LM. Schuchter LM. J Clin Oncol. 2004 Jan 1;22(1):7-10. doi: 10.1200/JCO.2004.10.907. Epub 2003 Dec 9. J Clin Oncol. 2004. PMID: 14665612 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

221 results

Search Page